Company intelligence / Profile preview

CPTone Biotech

Aarhus, Midtjylland, Denmarklife-sciences-europe.com ↗

Ownership: Private
Development stage: Other

Overview

CPTone Biotech is a Danish biotech company based in Aarhus, founded in 2008. The company focuses on developing new treatments for multiple sclerosis and has advanced its lead program to preparations for a phase II clinical study. Recent developments include hiring an experienced CEO with backgrounds at Pfizer, Leo Pharma, and Sanofi, and securing new private investment to support clinical progress[2].

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on CPTone Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CPTone Biotech.

Explore the full profile